Novel approaches to treating cardiovascular disease: lessons from Tangier disease

Bibliography

• GUYTON JR, KLEMP KF: Development of the lipid-rich core in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. (1996) 16:4–11.
   PubMed Web of Science ®Google Scholar
• LEE RT, LIBBY P: The unstable atheroma. Arterioscler. Thromb. Vasc. Biol. (1997) 17:1859–1867.
   PubMed Web of Science ®Google Scholar
• KANNEL WB: The Framingham Study: ITS 50-year legacy and future promise. J. Atheroscler. Thromb. (2000) 6:60–66.
   PubMedGoogle Scholar
• WILLIAMS KJ, TABAS I: The response-to-retentionhypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. (1995) 15:551–561.
   PubMed Web of Science ®Google Scholar
• BROWN MS, GOLDSTEIN JL: A receptor-mediatedpathway for cholesterol homeostasis. Science (1986) 232:34–47.
   PubMed Web of Science ®Google Scholar
• LAROSA JC, HE J, VUPPUTURI S: Effect of statins on riskof coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 282:2340–2346.
   PubMed Web of Science ®Google Scholar
• SEGREST JP, LI L, ANANTHARAMAIAH GM, HARVEY SC, LIADAKI KN, ZANNIS V: Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr. Opin. Lipidol. (2000) 11:105–115.
   PubMed Web of Science ®Google Scholar
• SEGREST JP, JONES MK, DE LOOF H, BROUILLETTE CG, VENKATACHALAPATHI YV, ANANTHARAMAIAH GM: The amphipathic helix in the exchangeable apolipo-proteins: a review of secondary structure and function. J Lipid. Res. (1992) 33:141–166.
   PubMed Web of Science ®Google Scholar
• ASZTALOS BF, ROHEIM PS: Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler. Thromb. Vasc. Biol. (1 99 5) 15:1419-1423.
   Google Scholar
• GORDON DJ, KNOKE J, PROBSTFIELD JL, SUPERKO R, TYROLER HA: High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation (1986) 74:1217–1225.
   PubMed Web of Science ®Google Scholar
• TALL AR: Plasma high density lipoproteins. Metabo-lism and relationship to atherogenesis. j Clin. Invest. (1990) 86:379–384.
   PubMed Web of Science ®Google Scholar
• NAVAB M, BERLINER JA, WATSON AD et al.: The Yin andYang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. (1996) 16:831–842.
   Google Scholar
• MILLER M, KWITEROVICH PO JR: Isolated low HDL-cholesterol as an important risk factor for coronary heart disease. ELIE Heart. J (1990) 11 (Suppl. H):9–14.
   Google Scholar
• FIELDING CJ, FIELDING PE: Molecular physiology of reverse cholesterol transport. J. Lipid. Res. (1995) 36:211–228.
   PubMed Web of Science ®Google Scholar
• •A review of the role of lipid-poor apolipoproteins in reverse cholesterol transport.
   Google Scholar
• ORAM JF, YOKOYAMA S: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. Lipid. Res. (1996) 37:2473–2491.
   PubMed Web of Science ®Google Scholar
• •See reference 14 for annotation.
   Google Scholar
• YOKOYAMA S: Apolipoprotein-mediated cellular cholesterol efflux [published erratum appears in Biochim Biophys Acta 1998 Jul 31,1393(1):222]. Biochim. Biophys. Acta (1998) 1392:1–15.
   PubMed Web of Science ®Google Scholar
• TALL AR: An overview of reverse cholesterol transport. Eur. Heart. J. (1998) 19 (SuppLA) :A31–35.
   Google Scholar
• RIGOTTI A, TRIGATTI BL, PENMAN M, RAYBURN H, HERZ J,KRIEGER M: A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B Type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA (1997) 94:12610–12615.
   PubMed Web of Science ®Google Scholar
• BROOKS-WILSON A, MARCIL M, CLEE SM etal.: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nature Genet. (1999) 22:336–345.
   Google Scholar
• •One of three papers in the same journal identifying ABCA1 as the Tangier disease gene product.
   Google Scholar
• BODZIOCH M, ORSO E, KLUCKEN J et al.: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genet. (1999) 22:347–351.
   PubMed Web of Science ®Google Scholar
• •See reference 19 for annotation.
   Google Scholar
• RUST S, ROSIER M, FUNKE H et al.: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genet. (1999) 22:352–355.
   PubMed Web of Science ®Google Scholar
• •See reference 19 for annotation.
   Google Scholar
• LAWN RM, WADE DP, GARVIN MR et al.: The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. (1999) 104 R25–31.
   PubMed Web of Science ®Google Scholar
• •Characterises ABCA1 as a rate-controlling step in this lipid secretory pathway.
   Google Scholar
• ORAM JF, VAUGHAN AM: ABCA1 -mediatedtransport of cellular cholesterol and phospholipids to HDL apolipoproteins. CULT. Op117. Lipid01. (2000) 11:253–260.
   Google Scholar
• •Reviews the molecular and cellular properties of ABCA1.
   Google Scholar
• ORAM JF: Tangier disease and ABCA1. Biochim. Biophys. Acta (2000) 1529:321–330.
   PubMed Web of Science ®Google Scholar
• KLEIN I, SARKADI B, VARADI A: An inventory of the human ABC proteins. Biochim. Biophys. Acta. (1999) 1461:237–262.
   PubMed Web of Science ®Google Scholar
• •Reviews the ABC transporter superfamily.
   Google Scholar
• WALKER JE, SARASTE M, RUNSWICK MJ, GAY NJ: Distantly related sequences in the a and b subunits of ATP synthase, myosin, kinases and other ATP requiring enzymes and a common nucleotide binding fold. EMBO J (1982) 8:945–951.
   Google Scholar
• LUCIANI MF, DENIZOT F, SAVARY S, MATTEI MG, CHIMINI G: Cloning of two novel ABC transporters mapping on human chromosome 9. Genornics (1994) 21:150–159.
   Google Scholar
• LANGMANN T, KLUCKEN J, REIL M et al.: Molecularcloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. (1999) 257:29–33.
   PubMed Web of Science ®Google Scholar
• PULLINGER CR, HAKAMATA H, DUCHATEAU PN et al.: Analysis of hABC1 gene 5' end: additional peptide sequence, promoter region and four polymorphisms. Biochem. Biophys. Res. Commun. (2000) 271:451–455.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ K, LAWN RM, WADE DP: ABC1 gene expres-sion and ApoA-I-mediated cholesterol efflux are regulated by DIR. Biochem. Biophys. Res. Commun. (2000) 274:794–802.
   PubMed Web of Science ®Google Scholar
• •Reports that LXR is the sterol-mediated regulator of ABCA1 gene expression.
   Google Scholar
• COSTET P, LUO Y, WANG N, TALL AR: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor /retinoid X receptor. J Biol. Chem. (2000) 275:28240-28245. See reference 30 for annotation.
   Google Scholar
• MENDEZ AJ, UINT L: Apolipoprotein-mediated cellularcholesterol and phospholipid efflux depend on a functional Golgi apparatus. J. Lipid. Res. (1996) 37:2510–2524.
   PubMed Web of Science ®Google Scholar
• REMALEY AT, SCHUMACHER UK, STONIK JA, FARSI BD,NAZIH H, BREWER HB, JR.: Decreased reverse choles-terol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. (1 9 9 7) 17:1813-1821.
   Google Scholar
• UN G, ORAM JF: Apolipoprotein binding to protrudingmembrane domains during removal of excess cellular cholesterol. Atherosclerosis (2000) 149:359–370.
   PubMed Web of Science ®Google Scholar
• ROTHBLAT GH, MAHLBERG FH, JOHNSON WJ, PHILLIPS MC: Apolipoproteins, membrane cholesterol domains and the regulation of cholesterol efflux. J. Lipid. Res. (1992) 33:1091–1097.
   PubMed Web of Science ®Google Scholar
• ORSO E, BROCCARDO C, KAMINSKI WE et al.: Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abel-deficient mice. Nature Genet. (2000) 24:192–196.
   PubMed Web of Science ®Google Scholar
• •Describes ABCA1 knockout mice.
   Google Scholar
• HAMON Y, BROCCARDO C, CHAMBENOIT 0 et al.: ABC1 promotes engulfment of apoptotic cells and transbi-layer redistribution of phosphatidylserine. Nature Cell. Biol. (2000) 2:399–406.
   Google Scholar
• •Characterises ABCA1 as promoting uptake of damaged cells by macrophages.
   Google Scholar
• ORAM JF, LAWN RM, GARVIN MR, WADE DP: ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. (2000) 275:34508–34511.
   PubMed Web of Science ®Google Scholar
• WANG N, SILVER DL, COSTET P, TALL AR: Specific binding of ApoA-I, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressingABC1 . J. Biol. Chem. (2000) 275:33053–33058.
   PubMed Web of Science ®Google Scholar
• ROSENBERG MF, CALLAGHAN R, FORD RC, HIGGINS CF:Structure of the multidrugresistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol. Chem. (1997) 272:10685–10694.
   Google Scholar
• CRAWFORD AR, SMITH AJ, HATCH VC, OUDE ELFERINKRP, BORST P, CRAWFORD JM: Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visuali-zation by electron microscopy. J Clin. /rives. (1997) 100:2562–2567.
   Google Scholar
• TAKAHASHI Y, SMITH JD: Cholesterol efflux to apolipo-protein Al involves endocytosis and resecretion in a calcium-dependent pathway. Proc. Natl. Acad. Sci. USA (1999) 96:11358–11363.
   PubMed Web of Science ®Google Scholar
• ORAM JF, MENDEZ AJ, SLOTTE JP, JOHNSON TF: High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterio-scler. Thromb. (1991) 11:403–414.
   PubMedGoogle Scholar
• MENDEZ AJ: Cholesterol efflux mediated by apolipo-proteins is an active cellular process distinct from efflux mediated by passive diffusion." Lipid Res. (1997) 3 8 :1807–1821.
   Google Scholar
• ORAM JF, MENDEZ AJ, LYMP J, KAVANAGH TJ, HALBERTCL: Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells. J. Lipid Res. (1999) 40:1769–1781.
   PubMed Web of Science ®Google Scholar
• MENDEZ AJ, ANANTHARAMAIAH GM, SEGREST JP, ORAMJF: Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. (1994) 94:1698–1705.
   PubMed Web of Science ®Google Scholar
• SANTAMARINA-FOJO S, PETERSON K, KNAPPER C et al.:Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl. Acad. Sci. USA (2000) 97:7987–7992.
   PubMed Web of Science ®Google Scholar
• VENKATESWARAN A, LAFFITTE BA, JOSEPH SB et al.:Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha. Proc. Natl. Acad. Sci. USA (2000) 97:12097–12102.
   PubMed Web of Science ®Google Scholar
• •Characterises regulation of ABCA1 and ABCG1 gene expres-sion by LXRs in macrophages.
   Google Scholar
• REPAB, MANGELSDORF DJ: Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr. Opin. Biotechnol. (1999) 10:557–563.
   PubMed Web of Science ®Google Scholar
• •Reviews nuclear receptors that regulate liver sterol and bile acid metabolism.
   Google Scholar
• SMITH JD, MIYATA M, GINSBERG M, GRIGAUX C, SHMOOKLER E, PLUMP AS: Cyclic AMP induces apolipo-protein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol. Chem. (1996) 271:30647–30655.
   PubMed Web of Science ®Google Scholar
• SAKR SW, WILLIAMS DL, STOUDT GW, PHILLIPS MC, ROTHBLAT GH: Induction of cellular cholesterol efflux to lipid-free apolipoprotein A- I by cAMP. Biochim. Biophys. Acta (1999) 1 43 8:85–98.
   Google Scholar
• BORTNICK AE, ROTHBLAT GH, STOUDT G et al.: Thecorrelation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. (2000) 275:28634–28640.
   PubMed Web of Science ®Google Scholar
• FRANCIS GA, KNOPP RH, ORAM JF: Defective removal ofcellular cholesterol and phospholipids by apolipopro-tein A-Iin Tangier disease. J. Clin. Invest. (1995) 96:78–87.
   PubMed Web of Science ®Google Scholar
• ASSMAN G, VON ECKARDSTEIN A, BREWER HB: Familialhigh density lipoprotein deficiency: Tangier disease. In: The Metabolic and Molecular Bases of Inherited Disease, Scriver CR, Sly WS, (Eds.) McGraw-Hill, New York, USA (1995) : 2053–2072.
   Google Scholar
• SCHAEFER EJ, BLUM CB, LEVY RI et al.: Metabolism ofhigh-density lipoprotein apolipoproteins in Tangier disease. N. Engl. J. Med. (1978) 299:905–910.
   PubMed Web of Science ®Google Scholar
• SCHAEFER EJ, ANDERSON DW, ZECH LA et al.: Metabo-lism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins. J. Lipid. Res. (1981) 22:217–228.
   PubMed Web of Science ®Google Scholar
• SERFATY-LACROSNIERE C, CIVEIRA F, LANZBERG A et al.:Homozygous Tangier disease and cardiovascular disease. Atherosclerosis (1994) 107:85–98.
   PubMed Web of Science ®Google Scholar
• HAYDEN MR, GLEE SM, BROOKS-WILSON A, GENEST J,JR., ATTIE A, KASTELEIN JJ: Cholesterol efflux regula-tory protein, Tangier disease and familial high-density lipoprotein deficiency. Curr. Opin. LipidoL (2000) 11:117–122.
   Google Scholar
• •Reviews ABCA1 and pattern of gene mutations.
   Google Scholar
• BROUSSEAU ME, SCHAEFER EJ, DUPUIS J et al.: Novelmutations in the gene encodingAIP-binding cassette 1 in four tangier disease kindreds. J. Lipid. Res. (2000) 41:433–441.
   PubMed Web of Science ®Google Scholar
• CLEE SM, KASTELEIN B, VAN DAM M et al.: Age andresidual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozy-gotes. j Clin. Invest. (2000) 106:1263–1270.
   Google Scholar
• •Reports relationships between cellular cholesterol efflux, plasma HDL levels and CVD among ABCA1 heterozygotes.
   Google Scholar
• WANG J, BURNETT JR, NEARS et al.: Common and rareABCA1 variants affecting plasma HDL cholesterol. Arterioscler. Thromb. Vasc. Biol. (2000) 20:1983–1989.
   PubMed Web of Science ®Google Scholar
• SCHAEFER EJ, ZECH LA, SCHWARTZ DE, BREWER HB, JR:Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann. Intern. Med. (1980) 93:261–266.
   PubMed Web of Science ®Google Scholar
• BROUSSEAU ME, EBERHART GP, DUPUIS J et al.: Cellularcholesterol efflux in heterozygotes forTtangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J. Lipid. Res. (2000) 41: 1125–1135.
   PubMed Web of Science ®Google Scholar
• •First report of the correlation between cellular cholesterol efflux and HDL levels and size in TD heterozygotes.
   Google Scholar
• MARCIL M, BROOKS-WILSON A, GLEE SM et al.: Mutationsin the ABC1 gene in familial HIDE deficiency with defective cholesterol efflux. Lancet (1999) 354:1341–1346.
   PubMed Web of Science ®Google Scholar
• MOTT S, YU L, MARCIL M, BOUCHER B, RONDEAU C,GENEST J: Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. Atherosclerosis (2000) 152:457–468.
   PubMed Web of Science ®Google Scholar
• MARCIL M, YU L, KRIMBOU L et al.: Cellular cholesteroltransport and efflux in fibroblasts are abnormal in subjects with familial HIDE deficiency. Arterioscler. Thromb. Vasc. Biol. (1999) 19: 159–169.
   PubMed Web of Science ®Google Scholar
• MARCIL M, BOUCHER B, KRIMBOU L et al.: Severe familial HDL de ficien cy in French-Canadian kin dr eds. Clinical, biochemical and molecular characterization. Arterioscler. Thromb. Vasc. Biol. (1995) 15:1015–1024.
   PubMed Web of Science ®Google Scholar
• MCNEISH J, AIELLO RJ, GUYOT D et al.: I-ligh density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad Sci. USA (2000) 97:4245–4250.
   PubMed Web of Science ®Google Scholar
• •See reference 36 for annotation.
   Google Scholar
• CHRISTIANSEN-WEBER TA, VOLAND JR, WU Y et al.: Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am.J. Pathol. (2000) 157:1017–1029.
   PubMed Web of Science ®Google Scholar
• •See reference 36 for annotation.
   Google Scholar
• REPA JJ, TURLEY SD, LOBACCARO JA et al.: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (2000) 289:1524–1529.
   PubMed Web of Science ®Google Scholar
• •Reports the effects of RXR and LXR agonists on intestinal cholesterol absorption and reverse cholesterol transport.
   Google Scholar
• ATTIE AD, BROOKS-WILSON A, GRAY-KELLER ME et al.: Massive cholesterol ester accumulation in hepatocytes and intestinal epithelial cells caused by ABC1 mutation in WHAM chickens. Circulation (2000) 102:312.
   Web of Science ®Google Scholar
• LUO Y, TALL AR: Sterol upregulation of human CE1P expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest. (2000) 105:513–520.
   PubMed Web of Science ®Google Scholar
• LAFFITTE BA, REPA JJ, JOSEPH SB et al.: L1CRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA (2001) 98:507–512.
   PubMed Web of Science ®Google Scholar
• BERGE KE, TIAN H, GRAF GA et al.: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 290:1771–1775.
   PubMed Web of Science ®Google Scholar
• REPA JJ, LIANG G, OU J et al.: Regulation of mouse sterolregulatory element-binding protein-lc gene (SREBP-1c) by oxysterol receptors, L1CRalpha and L1CRbeta. Genes. Dev. (2000) 14:2819–2830.
   PubMed Web of Science ®Google Scholar
• SCHULTZ JR, TU H, LUK A et al.: Role of L1CRs in controlof lipogenesis. Genes. Dev. (2000) 14:2831–2838.
   PubMed Web of Science ®Google Scholar